Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Non-Muscle Invasive Bladder Neoplasms 1Liposarcoma 1Inhibition of Autophagy Synergizes Anti-tumor Effect 1Gastrointestinal Neoplasms 1Disease Progression 1Digestive System Neoplasms 1Carcinoma in Situ 1Advanced Malignant Solid Tumors 1

Interventions

Doxorubicin 4pembrolizumab 3Specimen Handling 3toripalimab 2abemaciclib 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Biopsy 2silmitasertib 1selinexor 1peposertib 1pemigatinib 1pazopanib 1palbociclib 1mirdametinib 1liposomal doxorubicin 1X-Rays 1Vincristine 1Trabectedin 1Temozolomide 1Surgical Procedures, Operative 1Radiation 1Quality of Life 1Proton Therapy 1Neoadjuvant Therapy 1Irinotecan 1Injections 1Histamine H2 Antagonists 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liposarcoma × Clinical Trials, Phase II as Topic × Clear all
NCT06578624 2025-06-05

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Lamassu Bio Inc

Phase 1/2 Recruiting
70 enrolled
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡